GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 211 filers reported holding GLOBUS MED INC in Q2 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,532,000 | +31.6% | 74,027 | +17.3% | 0.75% | -7.3% |
| Q1 2020 | $2,684,000 | -27.8% | 63,110 | -0.1% | 0.81% | +6.0% |
| Q4 2019 | $3,718,000 | +16.2% | 63,146 | +0.9% | 0.76% | -10.2% |
| Q3 2019 | $3,200,000 | +19.7% | 62,589 | -1.0% | 0.85% | +24.6% |
| Q2 2019 | $2,673,000 | -48.1% | 63,193 | -39.4% | 0.68% | -52.8% |
| Q1 2019 | $5,155,000 | +32.0% | 104,323 | +15.7% | 1.45% | +12.9% |
| Q4 2018 | $3,904,000 | -27.9% | 90,199 | -5.4% | 1.28% | -17.8% |
| Q3 2018 | $5,414,000 | +33.9% | 95,381 | +19.0% | 1.56% | +8.6% |
| Q2 2018 | $4,043,000 | +108.1% | 80,120 | +105.4% | 1.44% | +15.2% |
| Q1 2018 | $1,943,000 | +35.9% | 39,008 | -38.4% | 1.25% | +25.2% |
| Q3 2016 | $1,430,000 | +4.4% | 63,360 | +10.2% | 1.00% | -12.0% |
| Q2 2016 | $1,370,000 | +134.2% | 57,470 | +133.3% | 1.13% | -8.0% |
| Q1 2016 | $585,000 | – | 24,630 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
| Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
| Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
| Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
| Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
| XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
| Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
| Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
| RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |